Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Methylation-Controlled J Protein

  • Janet C. Lindsey
  • Steven C. Clifford
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_3685-2



MCJ is a member of the DNAJ family of co-chaperone proteins, whose expression is controlled by methylation of its associated CpG island. Reduced MCJ expression increases resistance to several commonly used cancer therapeutics by inducing expression of the ABCB1 drug-transport pump.


The MCJ gene maps at 13q14.1 and codes for a protein of 150 amino acids and 16–17 kDa. MCJ contains a highly conserved 70 amino acid DNAJ domain (or J-domain) located at the C terminus. J-domain proteins interact with the heat shock protein 70 (Hsp70) family of chaperone proteins and act as co-chaperones recruiting Hsp70 members to specific substrate proteins. MCJ has been shown to be a type II transmembrane protein localized in the Golgi network, with a cytoplasmic N terminus and a C terminus lying within the Golgi lumen.

The expression of MCJ is epigenetically (Epigenetics) regulated by methylation...


Ovarian Surface Epithelium Epigenetic Gene Silence Sensitive Breast Cancer Cell Brain Tumor Type Supratentorial PNETs 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Hatle KM, Neveu W, Dienz O et al (2007) MCJ promotes c-Jun degradation to prevent ABCB1 transporter expression. Mol Cell Biol 27:2952–2966CrossRefPubMedPubMedCentralGoogle Scholar
  2. Lindsey JC, Lusher ME, Strathdee G et al (2006) Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours. Int J Cancer 118:346–352CrossRefPubMedGoogle Scholar
  3. Shridhar V, Bible KC, Staub J et al (2001) Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. Cancer Res 61:4258–4265PubMedGoogle Scholar
  4. Strathdee G, Vass JK, Oien KA et al (2005) Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy. Gynecol Oncol 97:898–903CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Northern Institute for Cancer ResearchNewcastle UniversityNewcastle upon TyneUK